A 16-week, Randomized, Open-label, Controlled Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine Versus Lantus in Patients With Type 1 Diabetes Mellitus
收藏DataCite Commons2024-12-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007686/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Primary Objective:
- To compare the glucose control during treatment with a new formulation of insulin
glargine and Lantus in adult participants with type 1 diabetes mellitus
Secondary Objectives:
- To compare a new formulation of insulin glargine and Lantus given in the morning or in
the evening
- To compare the incidence and frequency of hypoglycemic episodes
- To assess the safety and tolerability of the new formulation of insulin glargine
提供机构：
Vivli
创建时间：
2022-02-10
